Related Experiment Video
Updated: May 5, 2026

09:22
Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
Published on: May 12, 2020
5.3K
Mpox Keratitis: A Case Report and Review.
Christopher R Croasdale1, Eric Weinlander2, Thomas G Boyce3
1SSM Health, Davis Duehr Dean Clinic, Madison, WI.
Cornea
|July 5, 2024
Summary
Mpox keratitis is a rare but serious eye condition. Early diagnosis and treatment with tecovirimat can improve outcomes, though severe vision loss is possible. This review highlights key findings for eye care professionals.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Virology
Background:
- Mpox (formerly monkeypox) is a viral illness with potential ocular manifestations.
- Mpox keratitis, an infection of the cornea, is infrequently diagnosed, hindering effective patient management.
- Limited awareness among eye care professionals contributes to diagnostic challenges.
Purpose of the Study:
- To enhance knowledge of mpox keratitis among eye care professionals.
- To review the clinical presentation, diagnosis, and management of mpox keratitis.
- To report a unique case of successful corneal transplantation for mpox keratitis.
Main Methods:
- A systematic literature search identified 35 cases of mpox keratitis from 1970 to 2024.
- Analysis of case reports and abstracts to determine frequency, clinical features, and outcomes.
- Inclusion of a case study involving penetrating keratoplasty with a 20-year follow-up.
Main Results:
- Mpox keratitis occurs in 0.5%–1.0% of symptomatic mpox patients, with or without systemic disease.
- Initial misdiagnosis was common (40%); polymerase chain reaction (PCR) aids diagnosis.
- Corneal involvement varied from mild to severe; outcomes ranged from excellent vision to blindness.
- Tecovirimat showed efficacy in most cases without fulminant systemic disease.
- Successful penetrating keratoplasty was reported in one unique case.
Conclusions:
- Mpox keratitis, though rare, can lead to significant vision impairment and blindness.
- Systemic tecovirimat appears effective for mpox keratitis, but low incidence limits clinical trials.
- Topical steroids might prolong viral presence in the cornea.
- PCR is valuable for confirming corneal mpox infection.
Related Concept Videos
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

